Benefits, side effects, and warnings
Semaglutide effects: what held up and what did not
People tell many stories about this drug. The studies support some of them, while others remain reports rather than proof.
Which Semaglutide effects matter most?
Studies found weight loss, better blood sugar, less heart trouble, and fewer kidney problems in certain groups. The common price was stomach trouble. Nausea came up most at the start or after an increase.
The label also warns about a rare thyroid tumor seen in rats. Studies found more gallbladder trouble, too. People often gained weight after they stopped. You may also hear that thoughts of food grew quieter. Many people say so, but a personal report isn't a fair study.
The first list gives patient accounts. The next gives study findings and label warnings. That split helps you judge the trade.
What have people said happened?
These accounts come from patients and people using the drug for research. No controlled study checked these stories. They record what people noticed; they don't show that the drug caused it. No doses appear here.
Benefits people report
- Less thought about food: This comes up often. People say they feel full sooner. Many think less about their next meal. Some notice that in the first week or two.
- Fewer cravings: This comes up often. Some people lose much of their taste for sweets. Fried or greasy food may seem less tempting. A few begin to prefer lighter meals.
- Weight loss: This comes up often. Many people say their weight fell across several months. The pace often slows after the first stretch. Most link the loss to eating less.
- Steadier blood sugar: This is a common report. People with type 2 diabetes mention lower daily readings and a lower blood test covering three months. Some also report steadier energy.
- Less wish for alcohol: This comes up now and then. Some people say alcohol lost its pull when food cravings eased.
Trouble people report
- Nausea and sometimes vomiting: This is the leading complaint. Roughly a third of reviewers mention nausea. It often feels worst in the first weeks or after an increase. Many say it eases after one or two weeks. Rich food or too much food may bring it on.
- Bad-smelling burps: This is another common report. People call them egg-like or sulfur burps. Gas and an overfull feeling may come with them.
- Hard stools or diarrhea: People report both and may go back and forth. Stools may be hard and rare. Loose stools often follow rich food or a recent increase.
- Heartburn: This comes up now and then. It may arrive with burping, gas, or a recent increase.
- Tiredness at first: People often mention this after a shot. It may last a day or two, then ease with time.
- Changed taste or smell: This is less common. Meat or fatty food may seem bad. Some notice a metal taste or stronger smells. A few forget to eat because hunger is so low.
- Hair shedding and a leaner face: Some people notice both after fast weight loss. Shedding often starts a few months in. Many say it later stops.
- Headache or dizziness: These appear now and then. People often link them to too little food or drink.
- Sore skin where the shot went in: Some report redness, itch, a small bump, or mild pain. It doesn't often last long.

What does the safety record show about Semaglutide side effects?
The studies and drug label give a firmer list. Some harms happened in people. Other warnings come from rats or risks that aren't proved. Your own risk may differ.
Stomach trouble as the amount rises. Nausea, vomiting, diarrhea, and hard stools caused most trial trouble. They were also the main reason people stopped. One review said the trouble was usually mild or fair and soon passed [7]. A second found nausea in about one-third of patients [5]. Reports after sale also center on the stomach [10]. This isn't fine print. Slower movement of food helps the drug work, but may also make you sick.
The label's strongest warning comes from rat studies. This warning covers the GLP-1 drug group, whose drugs copy one gut hormone. Rats developed thyroid tumors after very high amounts. Human evidence hasn't established a higher thyroid cancer risk from Semaglutide [16]. Even so, the label says some people must not use it [5]. That includes people with type 2 multiple endocrine neoplasia, a rare illness that causes tumors in hormone-making glands. The illness is also called MEN-2. Your doctor can check whether your own or your family's history fits that warning. The rat finding is real; a matching danger in humans is still unproved.
Fast swelling of the pancreas. The medical name is acute pancreatitis. Care usually stops if a doctor suspects it. A review couldn't settle whether the drug was linked to pancreatic cancer because cases were rare [5]. That's a warning, not a measured rise in risk.
Gallstones and gallbladder trouble. One safety review counted more gallstones than with placebo [5]. The speed of weight loss may explain most of the difference. Still, the finding deserves notice.
Diabetes and eye trouble. SUSTAIN-6 found more trouble among patients with damage already present at the back of the eye. The 95% figure describes how sure researchers were, not how many patients were harmed. It showed higher risk but can't say how often harm would happen to you [2]. Blood sugar had fallen fast in those patients. The best reading is that the quick drop worsened eye trouble at first. A doctor may watch the eyes more closely then [5].
Some muscle went with the fat. A smaller study found loss of both fat and muscle [17]. Fast, large weight loss may leave an older person weaker. The study measured lost muscle. It didn't test whether that loss later made older people weaker.
Weight returned when use ended. After STEP 1, people regained a large share of what they had lost within a year [13]. Another fair test also found regain after the group switched to placebo [14]. The drug may help while it is used. The studies don't support calling it a cure.
Does Semaglutide hair loss come from the drug?
A review of side-effect reports picked up extra reports of hair loss with Semaglutide and tirzepatide [18]. A skin study tied the hair change to losing much weight fast [19].
The best fit is short-term shedding when weight falls fast. The body can shed hair the same way after a major illness or strain. Hair growth often returns. The drug itself seems less likely to be the cause.
The link is possible, but the reports don't prove a direct drug effect.
What other warnings are on the label?
Pregnancy needs a long pause. The label bars Semaglutide during pregnancy. Your body still holds roughly half after one week. Nearly all clears in roughly five weeks from the final dose. For a planned pregnancy, the label calls for stopping far ahead, often roughly two months [9]. That wait comes from the drug's slow exit.
Take the tablet before food. Only about 0.4-1% of oral Semaglutide gets into the blood [20]. A helper in the tablet lets more pass through the stomach. Even then, meals, drinks, or other drugs may block much of it. Your stomach must be empty, says the label, with little water [9]. That rule changes how well the pill works, not how poisonous it is.
Some pills need a closer watch as the amount rises. A review of the GLP-1 group, drugs that copy one gut hormone, found few major clashes with other pills. It still urged care when even a small change could matter [15]. Overall, the risk looked low.
How did the uses change over time?
Semaglutide grew from the GLP-1 group, medicines that copy one gut hormone. A change that blocks DPP-4, the body's quick breakdown protein, helps it last. In 2017, the FDA first approved it for type 2 diabetes [1]. The pill followed in 2019-2020. Long-term weight use came in 2021.
In 2023, a large study counted fewer major heart problems [3]. A kidney study reported fewer major kidney problems in 2024 [6]. Related heart and kidney uses gained approval in 2024 and 2025. A use for MASH followed in 2025 [8]. MASH is a serious fatty-liver illness.
From about 2022 through early 2025, the country faced a shortage. Special pharmacies could mix Semaglutide during that time. The route narrowed once the shortage ended [2].
The approved uses grew. An ad can still claim too much.